Babesiosis in humans (lecture)
https://doi.org/10.22627/2072-8107-2023-22-1-56-61
Abstract
Babesiosis is a natural focal infectious disease caused by protozoa of the genus Babesia, transmitted transmissibly and characterized by fever, intoxication, progressive hemolytic anemia, and often severe course in immunocompromised patients. The clinical picture of babesiosis is nonspecific. The disease should be suspected in patients with unexplained fever who have been in endemic areas for 2 months or have received a blood transfusion within 6 months. Diagnosis of babesiosis is difficult; depends on the qualifications of the doctor and the number of parasites in the blood. The aim of the work is to summarize the available information about the etiology, epidemiology, pathogenesis, clinic, diagnosis, etiotropic therapy and prevention of babesiosis in humans. A review of domestic and foreign literature over the past 30 years, including Internet resources, has been carried out.
About the Authors
E. V. Barakina
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Barakina Е., PhD
Saint-Petersburg
V. N. Timchenko
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Timchenko V., МD, Professor
Saint-Petersburg
T. Chernova
St. Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Chernova Т., PhD
Saint-Petersburg
References
1. Akel T., Mobarakai N. Hematologic manifestations of babesiosis. Ann Clin Microbiol Antimicrob. 2017; 16:6.
2. Edouard Vannier, Benjamin E. Gewurz, Peter J. Krause. Human Babesiosis. Infect Dis Clin North Am. 2008 Sep; 22(3):469—ix. doi:10.1016/j.idc.2008.03.010
3. Tokmalaev A.K., Chentsov V.B., Malov V.A., Maleev V.V. et al. Human babesiosis: clinical cases in the European part of the Russian Federation. Terapevticheskiy Аrkhiv=Therapeutic Аrchive. 2019; 11:60—65. (In Russ.)
4. Hatcher J.C., Greenberg P.D., Antique J., Jimenez-Lucho V.E. Severe Babesiosis in Long Island: Review of 34 Cases and Their Complications. Clin Infect Dis. 2001; 32(8):1117—1125.
5. Skrabalo Z, Deanovic Z. Piroplasmosis in man; report of a case. Doc Med Geogr Trop. 1957; 9(1):11—6.
6. Western KA, Benson GD, Gleason NN, et al. Babesiosis in a Massachusetts resident. N Engl J Med. 1970; 283(16):854—6.
7. Zelya O.P., Kukina I.V. Human babesiosis. Meditsinskiy vestnik Severnogo Kavkaza = Medical Bulletin of the North Caucasus. 2020; 15(3):449—455. (in Russ.)
8. Rabinovich S.A., Voronina Z.K., Stepanova N.I. The first discovery of human babesiosis in the USSR and a brief analysis of the cases described in the literature. Meditsinskaya parazitologiya i parazitarnyye bolezni=Medical Рarasitology and Рarasitic Diseases. 1978; 3:97—107. (In Russ.)
9. Samoilovskaya N.A., Uspensky A.V., Novosad E.V. Hemosporidiosis of agricultural, domestic and wild animals on the territory of the Russian Federation. Rossiyskiy parazitologicheskiy zhurnal=Russian Journal of Parasitology. 2015; 3:37—44. (In Russ.)
10. Semenov V.A., Maltsev B.B. A case of simultaneous infection with tick-borne encephalitis and babesiosis. Meditsina v Kuzbasse=Medicine in Kuzbass. 2004; 3:43—44. (In Russ.)
11. Babesiosis. CDC. DPDx — Laboratory Identification of Parasites of Public Health Concern. https://www.cdc.gov/dpdx/babesiosis/index.html
12. Ankit P., Surabhi B., Meredith S., Aravind L., Krause P.J. Babesia microti: Pathogen Genomics, Genetic Variability, Immunodominant Antigens, and Pathogenesis. Front. Microbiol., 03 September 2021.| https://doi.org/10.3389/fmicb.2021.697669.
13. Bloch E.M., Krause P. J., Tonnetti L. Preventing Transfusion-Transmitted Babesiosis. Pathogens, 2021; 10 (9):1176.
14. Wormer G.P., Dattwyler R.J., Shapiro E.D., Halperin J.J., Steere A.C., at all. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 1; 43(9):1089—134. doi:10.1086/508667.
15. Laboratory diagnosis of malaria and babesiosis: Guidelines. M.: FBUZ «Federal Center for Hygiene and Epidemiology» of Rospotrebnadzor, 2015:43. (In Russ.)
16. Hildebrandt A., Zintl A., Montero E., Hunfeld K.P., Gray J. Human Babesiosis in Europe. Pathogens. 2021; 10:1165—1194.
17. Jia N., Zheng Y-C., Jiang J-F., Jiang R-R, Jiang B-G, at all. Human Babesiosis Caused by a Babesia crassa—Like Pathogen: A Case Series. Clinical Infectious Diseases. 2018; 67(7):1110—9.
18. Ord R. L., Lobo C. A. Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment. Curr. Clin. Microbiol. Rep. 2015; 2(4): 173—181.
19. Renard I, Mamoun C.B. Treatment of Human Babesiosis: then and now. Pathogens. 2021 Sep; 10(9):1120.
20. Vannier E., Krause Peter J. Human Babesiosis. The New England Journal of Medicine, 2012 Jun 21; 366(25):2397—407. doi:10.1056/NEJMra1202018.
21. Skripchenko N.V., Ivanova G.P. Tick-borne neuroinfections in children: Guide for doctors. Medicine, 2008:424. (In Russ.)
22. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2020. State report. M.: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2021:256. (In Russ.)
Review
For citations:
Barakina E.V., Timchenko V.N., Chernova T. Babesiosis in humans (lecture). CHILDREN INFECTIONS. 2023;22(1):56-61. (In Russ.) https://doi.org/10.22627/2072-8107-2023-22-1-56-61
Views:
659
Email this article 